Skip to contentClarengateINTELLIGENCE
Companies/OC390205

The Christie Pathology Partnership LLP

Limited Liability Partnership · Withington

ActiveUnited KingdomIncorporated 2014Limited Liability Partnership
Register Ask analyst

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

No processed account filings

No processed accounts are available in our records.

Registered details

OC390205
Status
Active
Type
Limited Liability Partnership
Incorporated
2014-01-07
Jurisdiction
—
Registered office
550, WILMSLOW ROAD, WITHINGTON, MANCHESTER, M20 4BX, UNITED KINGDOM

Classification

1 SIC codes
03112

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

0 SH01-derived rounds

No reconstructed allotment rounds.

Research and innovation

4 matched grants
A coordinated strategy to scale-up advanced therapies for patient in Manchester
Innovate UK · Centres · 2021-04-01 – 2022-03-31 · with 11 other participants
£24,803
awarded
Manchester University NHS Foundation Trust£270,594
The Christie NHS Foundation Trustlead£252,199
The Christie Pathology Partnership LLP£24,803
Sheffield Teaching Hospitals NHS Foundation Trust£0
A coordinated strategy to scale-up advanced therapies for patient in Manchester
ISCF · Centres · 2021-03-31 – 2022-03-30 · with 12 other participants
£1,759,515
whole project
The Christie NHS Foundation TrustleadAgentus Therapeutics LtdAptus Clinical LimitedAstrazeneca UK LimitedChaucer Group LimitedDatatrial LimitedFormedix LimitedGlobal Life Sciences Solutions Operations UK LtdInstil Bio (UK) LimitedManchester University NHS Foundation TrustSheffield Teaching Hospitals NHS Foundation TrustThe Christie Pathology Partnership LLPThe University Of Manchester
A coordinated strategy to scale-up advanced therapies for patients in Manchester
Innovate UK · Collaborative R&D · 2018-03-01 – 2022-04-30 · with 12 other participants
£404,585
awarded
The Christie NHS Foundation Trustlead£1,997,573
Manchester University NHS Foundation Trust£1,141,375
The Christie Pathology Partnership LLP£404,585
Northern Care Alliance NHS Foundation Trust£0
A coordinated strategy to scale-up advanced therapies for patients in Manchester
ISCF · Collaborative R&D · 2018-03-01 – 2022-04-29 · with 12 other participants
£7,561,118
whole project
The Christie NHS Foundation TrustleadAgentus Therapeutics LtdAptus Clinical LimitedAstrazeneca PLCAsymptote LimitedCellular Therapeutics LtdChaucer Group LimitedDatatrial LimitedFormedix LimitedManchester University NHS Foundation TrustNorthern Care Alliance NHS Foundation TrustThe Christie Pathology Partnership LLPThe University Of Manchester